This message was sent to ##Email##
|
|
|
|
|
| |
| ACS CANCER PROGRAMS UPDATES |
ACS
April 7–9, 2019 – Rosemont (Chicago), Illinois
The 2019 Cancer Programs Cluster Workshops will be three individual one-day workshops on consecutive days, in one location, for your convenience. You may attend just one workshop or all three. Sign up here for further information as it becomes available.
2019 Call for Data
Due to the many changes and implementation delays in 2018, the NCDB 2019 Call for Data schedule will be adjusted to allow software vendors time to install v18 for their customers and registries an opportunity to catch up with abstracting the new data items and resubmit RQRS cases. At this time, the 2019 Call for Data is scheduled for April 1–June 30, 2019, and both NAACCR v16 and v18 layouts will be accepted for submission.
As the NCDB prepares to roll out the Rapid Cancer Reporting System (RCRS) with our new technology partner IQVIA next year, we continue to build out the needed technological infrastructure to support this new system. RCRS will replace RQRS and other NCDB tools while introducing a single source of data submission for all of our hospital registries. RQRS has been down recently as some of these new development efforts have been integrated and tested. Read more.
STORE Manual
In response to the valuable feedback from cancer registrars, the STandards for Oncology Registry Entry (STORE) has been updated to allow users to save the document into the computer/local drive, copy and paste from the document, highlight and add comments. There were no changes in the text other than allowing these features. For clarifications on the STORE data items, please continue to utilize the CAnswer Forum. For program-specific questions, please contact ncdb@facs.org.
READ MORE
|
Promoted by
|
|
|
|
 |
ACS
The AJCC Cancer Staging Manual is the gold standard to help the cancer patient management team determine the correct stage for patients, allowing for the most appropriate care plan.
The AJCC Cancer Staging Manual is used by physicians and health care professionals throughout the world to facilitate the uniform description and reporting of neoplastic diseases. Proper classification and staging of cancer is essential for the physician to assign proper treatment, evaluate results of management and clinical trials, and to serve as the standard for local, regional and international reporting on cancer incidence and outcome.
This corrected third printing includes the following features:
- Revised breast cancer staging system
- Revised histology codes in each chapter
- Corrected errata posted on www.cancerstaging.org through Feb. 2.
Special 25 percent discount! Expires Dec. 31.
Click here for the Springer order form.
READ MORE
 |
|
Our ihcDirect® method yields a revolutionary technology that opens a spectrum of new clinical applications including intraoperative surgery. Using the Novodiax PolyHRP technology, Intraoperative IHC tests can now be completed in just 10 minutes using fresh frozen tissues.
For more details, see our
 ihcDirect® product list.
|
|
AJCC
The AJCC Cancer Staging Manual, Eighth Edition is the first edition to have an electronic book (eBook) version. It is available for purchase now on Amazon and is the most current version of the manual (September 2018).
Since 1977, the American Joint Committee on Cancer (AJCC) has published eight editions of cancer staging manuals using contemporary, evidenced-based literature to build a common language of cancer for the care of cancer patients by clinicians and for the cancer surveillance community. The print version of the eighth edition was first published in October 2016 and went into effect for all cancer cases diagnosed on or after Jan. 1, 2018. The eighth edition presents evidence-based revisions for the staging of cancer for a number of organ sites. The chapters include the rationale and rules for staging; the definitions of tumor, lymph node involvement and metastasis; stage groupings; and histologic grade.
There have been updates since the first printing of the eighth edition, all of which are incorporated in this eBook version available through Amazon’s Kindle. The Kindle version can be used on any device (PC, MAC, iPhone, iPad, Android) with the free Kindle app. The electronic version allows for highlighting, adding notes and bookmarks and creating flashcards. The AJCC has a curated FAQ document to address common questions that can be accessed at cancerstaging.org. All other questions related to the eighth edition can be sent to ajcc@facs.org.
READ MORE
|
Promoted by
|
|
|
|
 |
The 2019 Commission on Cancer (CoC) annual accreditation fees will remain the same as in 2018 for all program categories, except Integrated Network Cancer Programs (INCPs). The National Accreditation Program for Breast Centers (NAPBC) and National Accreditation Program for Rectal Cancer (NAPRC) fees will also stay the same in 2019.
READ MORE
American College of Surgeons - NAPRC
The National Accreditation Program for Rectal Cancer (NAPRC) is now accepting applications. The NAPRC was developed to ensure that rectal cancer patients receive appropriate care following a multidisciplinary approach. Programs will be evaluated on the standards and metrics outlined in The National Accreditation Program for Rectal Cancer Standards Manual 2017 (revised October 2017).
READ MORE
 |
|
Doctors Without Borders/Médecins Sans Frontières (MSF) is actively recruiting general and trauma surgeons with experience in emergency obstetrics for international missions in developing countries. Learn more
|
|
Clinical Research Program
As mentioned in prior communications, the 2018 DCIS Special Study opened July 16. We invite you to visit the 2018 Special Study on DCIS SharePoint site, which will house all materials you will need to participate in the study. We have created a universal login for this site; please note it is case sensitive:
Login: DCISStudy
Password: study2018.
All registrars and co-registrars will be able to access and download materials via the SharePoint site.
READ MORE
| HEALTH CARE NEWS AND UPDATES |
Elsevier via ScienceDaily
To improve outcomes for patients with non-small-cell lung carcinoma researchers are developing a blood test to detect lung cancer earlier in the disease. A report describes a new technology, electric field-induced release and measurement (EFIRM) that is both highly sensitive and specific in detecting two epidermal growth factor receptor (EGFR) mutations associated with lung cancer in the blood of NSCLC patients with early-stage disease.
READ MORE
 |
|
Dynamic online courses from the Association of Community Cancer Centers (ACCC) offer the tools your staff needs to help patients pay for treatment—while maximizing reimbursement at your cancer program. The Financial Advocacy Boot Camp explains all aspects of financial advocacy and is a great resource for new advocates and experienced professionals. Your team will be more prepared with this online curriculum. Learn More
|
|
University of Melbourne via Futurity
Ovarian cancer is hard to detect and often goes without diagnosis until an advanced stage, leading to a five-year survival rate of just 43 percent. Like many other cancers, research shows it is not a simple single disease, but actually multiple diseases driven by a range of molecular differences. Arming doctors with more precise treatment options is part of the answer. The new study adds to a “checklist” of options to match the right treatment to each individual patient.
READ MORE
Targeted Oncology
Patients with cervical cancer have historically had limited treatment options, but immunotherapy may have been proven beneficial for this patient population with a new study of anti–PD-1 agent cemiplimab. The ongoing, open-label, multinational, randomized phase III trial GOG 3016/ENGOT-cx 9 (NCT03257267) compares cemiplimab with investigator’s choice of chemotherapy in the second-line for patients with recurrent or metastatic cervical cancer.
READ MORE
 |
|
Need to automate cancer coding at Budget Preserving costs? Let AI do the bulk coding and preserve valuable staff time for the most cryptic. HORIZON suite automates NAACR 2018 for 100% of your reportability assessments and 90%+ of your coding at better than manual accuracy, while undercutting manual costs. With ever-tightening budgets and workloads rising continuously and more data for analysis being demanded, www.hla-global.com
is your best option for the future.
|
|
Medscape
Despite guidelines from the American Society of Clinical Oncology (ASCO) "Choosing Wisely" initiative, many clinicians are not choosing wisely — at least when it comes to breast cancer imaging.
While guidelines recommend against routine imaging in patients with early-stage breast cancer (ESBC) who are at low risk for metastasis, two new studies have found that these guidelines are not being consistently followed.
READ MORE
Yale University via Medical Xpress
Yale researchers have identified factors that may contribute to widening cancer death disparities among counties across the United States. These factors, which include both socioeconomic and behavioral traits, may provide public health experts with specific targets for potentially reducing cancer disparities, the researchers said. The study was published in JAMA Network Open.
READ MORE
Healio
Postmenopausal women who lost weight over three years demonstrated a 12 percent decreased risk for breast cancer compared with women whose weight remained stable, according to an observational study published in Cancer. “Obesity is associated with increased risk of incident postmenopausal breast cancer,” Rowan T. Chlebowski, MD, PhD, researcher professor in the department of medical oncology and therapeutics research at City of Hope National Medical Center, and colleagues wrote.
READ MORE
KERA News
New guidelines in screening for cervical cancer include the option of HPV testing, a move that may soon signal the end for the Pap smear test. Cervical cancer used to be a common cause of death among American women. Today, the American Cancer Society says, 13,000 American women are diagnosed with cervical cancer each year — and 4,000 will die. Incomplete screening is the most common reason.
READ MORE
Healthline
Cancer is one of the leading causes of death worldwide.
But studies suggest that simple lifestyle changes, such as following a healthy diet, could prevent 30–50 percent of all cancers.
Growing evidence points to certain dietary habits increasing or decreasing cancer risk.
What’s more, nutrition is thought to play an important role in treating and coping with cancer.
READ MORE
| IMPORTANT DATES AND DEADLINES |
|
Missed last week's issue? See which articles your colleagues read most.
|
Don't be left behind. Click here to see what else you missed.
|
|
|
|
The Brief
Connect with AJCC
Connect with CoC
Connect with NAPBC
Recent Issues | Subscribe | Unsubscribe | Advertise | Web Version
Colby Horton, Vice President of Publishing, 469-420-2601 | Download media kit
Ashley Harrington, Senior Content Editor, 469-420-2642 | Contribute news
Disclaimer: The Brief is a digest of news selected for the Commission on Cancer (CoC) and the National Accreditation Program for Breast Centers (NAPBC), both quality programs of the American College of Surgeons, from thousands of sources by the editors of MultiBriefs, an independent organization that also manages and sells advertising. The Cancer Programs do not endorse any of the advertised products and services. Opinions expressed in the articles are those of the authors and not of the American College of Surgeons, and the Cancer Programs.
American College of Surgeons
633 N Saint Clair Street | Chicago, IL, 60611-3211 | 800-621-4111 | Contact Us
Learn how to add us to your safe sender list so our emails get to your inbox. |
|
| |
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
